Counsel-directed physician comparison of selected behavioral-health utilization-management limitations with analogous medical/surgical processes, identifying clinical differences, evidence gaps, and issues requiring legal and multidisciplinary review.
Side-by-side clinical comparison of the selected limitation across applicable mental health/substance-use and medical/surgical benefit classifications, with the factors, sources, evidentiary standards, and processes identified.
For each scoped limitation, a direct comparison of written clinical criteria and review processes, identifying differences that require explanation, additional evidence, or counsel’s legal assessment.
Clinical explanation of how the compared criteria and processes operate, where the medical rationale is documented, and where the supplied materials do not support a clear comparison.
Relevant public regulatory and agency materials are identified for counsel’s review. The deliverable remains a physician clinical workstream and does not present legal conclusions.
Each scoped issue is categorized by the strength of the clinical explanation and completeness of the evidence, with a data-request or clarification list where needed.
The report identifies the plan configuration, benefit classifications, vendors, documents, operational data, and professional workstreams included and excluded.
You represent a self-insured employer plan sponsor facing a DOL NQTL inquiry or an MHPAEA enforcement action and need a physician to document the criteria disparity.
You are advising a regional insurance carrier on pre-enforcement NQTL self-assessment ahead of a DOL or HHS audit cycle.
A plan sponsor client is facing a member lawsuit alleging parity violations and you need physician-authored documentation of what the criteria actually say and how they compare.
You are responding to a DOL RFI or civil investigative demand and need a structured, physician-authored criteria comparison to submit as supporting documentation.
Required inputs from client: Summary Plan Description (SPD), clinical criteria manuals (InterQual/MCG/proprietary), Evidence of Coverage (EOC), any prior NQTL self-assessment the plan has conducted.
This is not: a legal opinion, a compliance certification, a guarantee of regulatory adherence, or an attestation that the plan is or is not in compliance. Legal and regulatory conclusions are the responsibility of retained counsel.
The MHPAEA Behavioral Health Parity Review provides the physician clinical-criteria component of a broader NQTL comparative analysis. It can compare medical-necessity criteria, prior authorization, concurrent review, fail-first logic, and related clinical factors across mental health/substance-use and medical/surgical benefits.
The statutory obligation to perform and document comparative analyses of the design and application of NQTLs remains in effect. Federal agencies have maintained a nonenforcement policy for portions of the 2024 final rule that are new relative to the 2013 rule while litigation proceeds, but the underlying CAA 2021 comparative-analysis duty continues. The engagement must therefore be scoped to the governing law and counsel’s current interpretation rather than marketed as a static checklist.
A physician is particularly useful where the disputed factors involve clinical thresholds, evidentiary standards, review pathways, guideline selection, or the operation of utilization management. Legal sufficiency, quantitative testing, network composition, fiduciary certification, and final compliance conclusions require the appropriate counsel and other professionals.
Counsel identifies the limitation, plan configuration, benefit classifications, vendors, products, and governing period to be examined.
Policies, criteria, evidentiary standards, decision trees, training materials, and exceptions are mapped for MH/SUD and comparable M/S benefits.
The report examines whether the factors, sources, weights, and processes are described and applied comparably in the written materials.
Denial files, authorization data, turnaround, escalation, exception handling, and reviewer practices are examined only to the extent reliable operational evidence is supplied.
The physician narrative states the clinical comparison, unresolved evidence needs, and risk flags without issuing a legal certification.
“Review the plan for parity” is not a workable physician scope. The engagement must identify the NQTL, benefit classifications, plan documents, vendor materials, and operational evidence to be compared.
The deliverable is designed to fit within a multidisciplinary parity project.
Federal agencies have stated a nonenforcement policy for provisions new to the 2024 rule while litigation proceeds, plus the stated post-litigation period. The CAA 2021 comparative-analysis obligation continues. Counsel should confirm the current posture at engagement.
No. Medisprudence provides the physician clinical component and evidence-gap analysis under counsel’s direction.
One defined NQTL, identified plan configuration, applicable benefit classifications, specified vendors, and a clear distinction between as-written and in-operation work.
Yes. They can provide operational evidence, but sample design, data completeness, and the limits of any inference must be stated.
Full-format specimen with fictional plan data. Side-by-side NQTL table, risk grading, and physician narrative across selected utilization-management limitations and applicable benefit classifications.
The Clinical Denial Pattern Audit reviews a sample of the plan's actual denial decisions — whether criteria were applied defensibly in practice, not just on paper.
Send only the plan type and general scope first — no documents required to initiate a conversation.